Driving Collaboration in Drug Development
Integrated teams, data visualization, and coordination between clinical, regulatory, and commercial functions can accelerate decision-making and development speed.
Ben Edwards, COO of Avance Clinical, discussed challenges in biotech, emphasizing the importance of addressing preclinical package gaps and obtaining patient data early.
He highlighted the need for CROs with deep scientific capabilities to create a sound scientific argument for new drugs.
- Importance of addressing preclinical package gaps to avoid delays
- Need for CROs with deep scientific capabilities
- Shift towards adaptive trial designs
- Benefits of staying with the same CRO for continuity
Author's summary: Collaboration accelerates drug development.
More News
- Dean Lewis Shares Statement Following Misconduct Allegations
- NewJeans to Appeal Label Contract Court Decision
- Coup scare: DSS and selective use of state power
- City unveils plan for new stage, remodel of Coleman Hawkins Park next spring
- 2025 NBA Cup TRACKER: Scores, Schedule, Standings
- How MorningStar and Anthem Are Revamping Scheduling and Staffing Efficiency
- Billie Eilish Calls on Billionaires to Do More for People in Need
- Stranger Things 5 trailer shows way more than we were ready for
- Schenectady man gets 4 years in prison on gun charge
- Performa brings digital doubles, kids reciting animal noises and more to New York